Thu, Nov 27, 2014, 7:04 AM EST - U.S. Markets closed for Thanksgiving Day

Recent

% | $
Quotes you view appear here for quick access.

Zalicus Inc. Message Board

nytonc1979 128 posts  |  Last Activity: Nov 12, 2014 8:12 PM Member since: Oct 19, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • nytonc1979 by nytonc1979 Nov 12, 2014 8:12 PM Flag

    you all are. Pumpers and bashers. Disgusting to know that the human race consists of people like you. Whether you are paid by KNDI to pump your BS, or paid by Mark Cuban to bash. Disgusting all around. Makes it so hard to invest in a company you believe in. What a bunch of trash. Either case is losing right now. This thing is one the fence, its not going to crash to 2, and it's not going to the moon anytime soon. As a planned long term investor, I am disgusted with the PPS being about what i started at a year ago for a company with explosive growth throughout the year. What a wasted year. Useless even looking on this message board anymore. I'm sure the shorts will have there way with this over the next couple months, i am l holding some long but had to sell off some today. sickening manipulated performance all around. OUT

  • Nothing like droping 6 plus percent right before earnings are announced. Bought in at 24, looking forward to being down on yet another stock this evening.

  • nytonc1979 by nytonc1979 Oct 11, 2014 10:28 AM Flag

    Im long kndi and quite underwater on it. I believe in the company and feel that these short hit pieces are a setup to get the price down because they know this one will fly with repeated good earnings and expansion. My concern though is on analyst coverage. Also surprised me that at almost 50% drop from highs these crooks are claiming best short idea, maybe at 22, at 12 it's a little late to the party i would hope. I'm new this year to investing so perhaps someone serious could explain this to me about analyst coverage. Why does this stock have none? I have stocks much smaller and under the radar that have analyst coverage. Are there any other examples of great stocks that have run with no analyst coverage? It also seems to be a popular short attack point. You would think some firm would step up, and give it a rating and price target at this point. Any thoughts?

    Sentiment: Hold

  • nytonc1979 by nytonc1979 Oct 10, 2014 7:01 PM Flag

    I have just started investing this year, and have held up ok this year until September and portfolio is down 33% since then, needing a 50% gain to get back even. Major contributor is GSAT. I have been hit on every small cap i own, but this one is ridiculous.

    This kind of attack is new to me, and makes me wonder why anyone even invests their hard earned money in this crooked game when this can happen for no reason. How can one $%#hole take down over 50% value of a stock in a week because they give a short attack thesis on it. Nothing fundamentally has changed and it continues to drop. I thought averaging down at 2.40 was a great move, never imagined that this could continue this far.

    I am so sick to my stomach by this months losses, I went to sell after hours like the rest of the sheeple falling into this ^*&9&holes games, then I looked at the chart and just couldnt do it. If i had been sitting out and just saw this stock at this price for no reason other then some guy and his crew short attacking it, I would be buying all i could. Ive seen drug companies fail phase II drug trials and not drop this much. Amazing. Then you have people waiting till 1.50 or 1.00.

    I know this post does no good to the share price, just like GSAT's presentation did no good yesterday. From what I have seen this year, Shorts ALWAYS win. Thieving #$%$ legally stealing my money. Something tells me it is a bad move to hold any longer as somehow this will go further, but I will hold with hopes that the real value of GSAT prevails. Next time i even hear hint of a short bear attack, I will sell and wait to buy back at 75% of the discount. Too bad the crooked thieving way is the profitable way, just like breaking into someones home and stealing there belongings is more profitable then working hard and buying them with integrity pride.

    Doing DD and investing long in companies you believe in is a joke.

  • nytonc1979 by nytonc1979 Sep 16, 2014 5:07 PM Flag

    why this garbage is dropping like a rock?

  • Reply to

    pretty dead here, and in the premarket????

    by knite1000 Jul 30, 2014 8:00 AM
    nytonc1979 nytonc1979 Jul 30, 2014 8:39 AM Flag

    All it takes is one hit piece. For some reason I thought it would be different this time. Similar to ONVO and INO, and now KNDI for the second time. I agree that long term we will do well. I have a large stake and am doing my best to hold, tough to watch all gains go away, but that's the game. To me, the chart looks like a range of 16 to 18 for a while and then a pop into new highs. Of course manipulation could change that.

  • Reply to

    pretty dead here, and in the premarket????

    by knite1000 Jul 30, 2014 8:00 AM
    nytonc1979 nytonc1979 Jul 30, 2014 8:22 AM Flag

    Most are probably tired of the games. I know I am. Typical market manipulation by crooks to knock it down just like every stock that gets a run lately, followed by a week of intense bashing and intense pumping. The stock is getting tired. Hopefully it floats in this range instead of crashing back to lows like last time. I know a PR from the company would do wonders.

  • nytonc1979 by nytonc1979 Jul 25, 2014 10:12 AM Flag

    Waiting to buy back the other half after some clarity comes to. I'm sure it will cost me, but without a PR from the company I see this drifting lower.

  • nytonc1979 by nytonc1979 Jul 23, 2014 10:26 PM Flag

    Just started investing end of 2013. I see countless stocks from last year that just climbed all year. Everytime i get a decent run on something, these hit pieces tear away my gains and sometimes turn to losses. Happened KNDI, ONVO, INO, and others. How did so many stocks just run in 2013? since I've started, no matter how good a company, these people come up with something and the street reacts to an extreme. It's like clockwork.

  • nytonc1979 nytonc1979 Jul 23, 2014 9:23 AM Flag

    Same boat, bought at 14 and held through last pop to 22 to watch all my gains go and then turn to loss down to 10, I feel there is more support this time and the company is proving itself, but I'm never comfortable after that until this thing hits 25 plus. Sold some yesterday and waiting for reentry.

  • nytonc1979 nytonc1979 Jul 22, 2014 10:51 PM Flag

    Agreed. Perfect cup, i sold some and am looking to pick back up in 18's on the handle before hitting new highs. Hard to be patient knowing it may not get that low. See what tomorrow brings.

  • nytonc1979 by nytonc1979 Jul 22, 2014 3:30 PM Flag

    preferably 18.50 so i can buy back my trading shares. Long term is no question where this is going.

  • nytonc1979 by nytonc1979 Jul 18, 2014 4:44 PM Flag

    Being new to biotech, what are we expecting from the trial update. I understand that it did not meet secondary endpoints, but there were some other improvements noted, are we waiting for an announcement of another phase II trial to be conducted with different expectations, or a phase III trial using the positive data from phase II for a different type of treatment? I'm not quite sure how it works. What are some possible catalysts from this update news. Its great that there were some other positive responses to this drug, but where does that take us being that it failed the phase II trials for what it was intended for. Any help would be appreciated.

  • nytonc1979 by nytonc1979 Jul 14, 2014 10:45 AM Flag

    I get to count on my ONCS losses offsetting any gains by my good picks, what a fool i was to double down before ASCO. This is getting disgusting at an average PPS of .82

  • nytonc1979 by nytonc1979 Jul 8, 2014 9:03 AM Flag

    Can anyone validate for sure if Purdue version contains acetaminophen? I thought that it did, which if that is the case, then there is no comparison. The whole idea behind zohydro is ACETAMINOPHEN free. Why is this never mentioned????

  • Every biotech i've bought in the last 6 months has dropped below dilution price eventually. Looking for 3.90 buy in. No matter how good i thought the company was or how much i was sure it was holding, they all hit it and then some.

  • Reply to

    if only i would have listen

    by splicerdog Jun 13, 2014 5:06 PM
    nytonc1979 nytonc1979 Jun 13, 2014 8:51 PM Flag

    I'm in the same boat. my average price is .82, I also own INO at average 3.25. I bought in at the peak of these damn stocks on all the hype and they are the worst ones in my portfolios but unfortunately the largest positions. i doubled my position before the ASCO and now am sick, but I am still holding and if this gets below 50, i will sell my INO beating and throw it into ONCS because I feel i have a better chance here.

  • nytonc1979 by nytonc1979 Jun 6, 2014 11:37 AM Flag

    This is the most manipulated stock I've ever seen. We don't have many overall green days lately, and this goes red everytime, even with good news. For a company with such potential and a great year so far, I can't believe I am under water still. And you can gaurantee on market down days this stock will tank. As much as I believe in this company and future, wishing I never bought into it with the way it's being manipulated by crooks

  • nytonc1979 by nytonc1979 Jun 4, 2014 11:33 AM Flag

    how long this SEC #$%$ will take? It's getting really old. Let's get it over and done with, are they going to keep pumping these scare articles for years? I personally don't really care if there was a bit of crooked activity, most companies are crooked, just some get called on it. That doesn't change the fact that this company has a huge future and a great product. What's it gonna take to stop getting beaten down?

  • Reply to

    Same old #$%$....

    by briangrainger Jun 3, 2014 6:37 PM
    nytonc1979 nytonc1979 Jun 3, 2014 6:41 PM Flag

    Nice post.

ZLCS
1.180.00(0.00%)Jul 15 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.